Johnson and Johnson is expected to release data on its vaccine in early January, according to a Dec. 22 report from FOX 31.
Moderna’s COVID-19 vaccine received emergency use authorization from the FDA Dec. 18, making it the second vaccine approved in the U.S.
The FDA is investigating reports of allergic reactions to the Pfizer-BioNTech COVID-19 vaccine.
Pfizer and Moderna are testing their COVID-19 vaccines against a mutated strain of the coronavirus that first appeared in England.
Hospital pharmacists discovered Dec. 16 that some vials of Pfizer’s COVID-19 vaccines that are supposed to hold five doses actually contain six or seven.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.